INTRODUCTION: Balneotherapy (BT) is the treatment of disease through the use of thermal spring water (TSW). It has been used for centuries and remains a popular form of treatment for dermatologic diseases such as atopic dermatitis (AD). Recent findings highlighted the role of the gut microbiota in AD and the possible crosstalk between gut and skin microbiomes in this pathology. Nevertheless, changes in the composition of the gut microbiota after balneotherapy remain to be elucidated. METHODS: A total of 96 patients, with moderate to severe AD according to the SCORAD, were enrolled. Stool samples were collected prior and post a 3-week balneotherapy at the thermal care center of La Roche-Posay (France). Composition of the gut microbiota was assessed by shotgun metagenomic sequencing. RESULTS: Species associated with high gut microbiota richness tended to correlate negatively with disease severity (SCORAD) and positively with SCORAD reduction, while species associated with low richness displayed the opposite pattern. Relative abundance of 23 species was significantly altered during BT, these changes being significantly associated with SCORAD reduction during BT, suggesting that gut microbiota composition and AD progression were associated through the treatment. Microbial functions related to gut-brain axis such as GABA and tryptophan metabolism were also altered by the treatment. Long-standing AD patients exhibited a better gut microbial profile than recently diagnosed patients, with higher MSP richness and species associated with SCORAD reduction. CONCLUSION: In patients with AD, clinical disease parameters such as SCORAD or disease duration are intricately linked to the gut microbiota composition. SCORAD reduction occurring during BT was also associated with gut microbiota. The gut-brain-skin axis via neurotransmitter such as GABA should be further studied in diseases such as AD.
INTRODUCTION: Balneotherapy (BT) is the treatment of disease through the use of thermal spring water (TSW). It has been used for centuries and remains a popular form of treatment for dermatologic diseases such as atopic dermatitis (AD). Recent findings highlighted the role of the gut microbiota in AD and the possible crosstalk between gut and skin microbiomes in this pathology. Nevertheless, changes in the composition of the gut microbiota after balneotherapy remain to be elucidated. METHODS: A total of 96 patients, with moderate to severe AD according to the SCORAD, were enrolled. Stool samples were collected prior and post a 3-week balneotherapy at the thermal care center of La Roche-Posay (France). Composition of the gut microbiota was assessed by shotgun metagenomic sequencing. RESULTS: Species associated with high gut microbiota richness tended to correlate negatively with disease severity (SCORAD) and positively with SCORAD reduction, while species associated with low richness displayed the opposite pattern. Relative abundance of 23 species was significantly altered during BT, these changes being significantly associated with SCORAD reduction during BT, suggesting that gut microbiota composition and AD progression were associated through the treatment. Microbial functions related to gut-brain axis such as GABA and tryptophan metabolism were also altered by the treatment. Long-standing AD patients exhibited a better gut microbial profile than recently diagnosed patients, with higher MSP richness and species associated with SCORAD reduction. CONCLUSION: In patients with AD, clinical disease parameters such as SCORAD or disease duration are intricately linked to the gut microbiota composition. SCORAD reduction occurring during BT was also associated with gut microbiota. The gut-brain-skin axis via neurotransmitter such as GABA should be further studied in diseases such as AD.
Authors: Ferda Cevikbas; Joao M Braz; Xidao Wang; Carlos Solorzano; Mathias Sulk; Timo Buhl; Martin Steinhoff; Allan I Basbaum Journal: J Allergy Clin Immunol Date: 2017-02-21 Impact factor: 10.793
Authors: Intan H Ismail; Frances Oppedisano; Shayne J Joseph; Robert J Boyle; Paul V Licciardi; Roy M Robins-Browne; Mimi L K Tang Journal: Pediatr Allergy Immunol Date: 2012-07-26 Impact factor: 6.377
Authors: Johanna M Gostner; Katrin Becker; Heinz Kofler; Barbara Strasser; Dietmar Fuchs Journal: Int Arch Allergy Immunol Date: 2016-05-04 Impact factor: 2.749
Authors: Nanna Fyhrquist; Gareth Muirhead; Stefanie Prast-Nielsen; Marine Jeanmougin; Peter Olah; Tiina Skoog; Gerome Jules-Clement; Micha Feld; Mauricio Barrientos-Somarribas; Hanna Sinkko; Ellen H van den Bogaard; Patrick L J M Zeeuwen; Gijs Rikken; Joost Schalkwijk; Hanna Niehues; Walter Däubener; Silvia Kathrin Eller; Helen Alexander; Davide Pennino; Sari Suomela; Ioannis Tessas; Emilia Lybeck; Anna M Baran; Hamid Darban; Roopesh Singh Gangwar; Ulrich Gerstel; Katharina Jahn; Piia Karisola; Lee Yan; Britta Hansmann; Shintaro Katayama; Stephan Meller; Max Bylesjö; Philippe Hupé; Francesca Levi-Schaffer; Dario Greco; Annamari Ranki; Jens M Schröder; Jonathan Barker; Juha Kere; Sophia Tsoka; Antti Lauerma; Vassili Soumelis; Frank O Nestle; Bernhard Homey; Björn Andersson; Harri Alenius Journal: Nat Commun Date: 2019-10-16 Impact factor: 14.919